by Catalin | Jun 25, 2025 | 2025 vol. 3 issue 2
The Benefit of Brentuximab Vedotin and Checkpoint Inhibitors in Relapsed/Refractory Hodgkin Lymphoma: A Single-Center Retrospective Study Diana-Marina FORTOES, Elena NICORICI, Cosmin MINCIUNA Andrei CIANGA, Ramona TIMOFTE, Amalia TITIEANU, Elena DOLACHI-PELIN, Ion...
by Catalin | Jun 25, 2025 | 2025 vol. 3 issue 2
Clinical Diversity and Treatment Outcomes in IgM Monoclonal Gammopathy Associated with Cold Agglutinin Disease and Cryoglobulinemia: A Single Center Study Larisa ZIDARU, Sinziana BARBU, Ruxandra DRAGHICI, Sebastian Nicolae TIMOTEI, Daniel CORIU, Sorina Nicoleta...